Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2017
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 10 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 02 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 30 Oct 2015 New trial record